Literature DB >> 11064826

Anti-CV2 autoantibodies and paraneoplastic neurological syndromes.

V Rogemond1, J Honnorat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11064826     DOI： 10.1385/CRIAI:19:1:51

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  12 in total

1.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Authors:  W P Mason; F Graus; B Lang; J Honnorat; J Y Delattre; F Valldeoriola; J C Antoine; M K Rosenblum; M R Rosenfeld; J Newsom-Davis; J B Posner; J Dalmau
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

2.  Analysis of the Caenorhabditis elegans axonal guidance and outgrowth gene unc-33.

Authors:  W Li; R K Herman; J E Shaw
Journal:  Genetics       Date:  1992-11       Impact factor: 4.562

3.  Autoimmunity in paraneoplastic neurological disorders.

Authors:  A Vincent; J Honnorat; J C Antoine; B Giometto; J Dalmau; B Lang
Journal:  J Neuroimmunol       Date:  1998-04-01       Impact factor: 3.478

4.  POP66, a paraneoplastic encephalomyelitis-related antigen, is a marker of adult oligodendrocytes.

Authors:  J Honnorat; M Aguera; B Zalc; C Goujet; T Quach; J C Antoine; M F Belin
Journal:  J Neuropathol Exp Neurol       Date:  1998-04       Impact factor: 3.685

5.  Molecular cloning of a new unc-33-like cDNA from rat brain and its relation to paraneoplastic neurological syndromes.

Authors:  T T Quach; Y Rong; M F Belin; A M Duchemin; H Akaoka; S Ding; M Baudry; P E Kolattukudy; J Honnorat
Journal:  Brain Res Mol Brain Res       Date:  1997-06

6.  Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor.

Authors:  V de la Sayette; F Bertran; J Honnorat; S Schaeffer; S Iglesias; G Defer
Journal:  Arch Neurol       Date:  1998-03

7.  A family of rat CRMP genes is differentially expressed in the nervous system.

Authors:  L H Wang; S M Strittmatter
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

8.  Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina.

Authors:  J C Antoine; J Honnorat; C Vocanson; F Koenig; M Aguera; M F Belin; D Michel
Journal:  J Neurol Sci       Date:  1993-07       Impact factor: 3.181

9.  The Ulip family phosphoproteins--common and specific properties.

Authors:  T Byk; S Ozon; A Sobel
Journal:  Eur J Biochem       Date:  1998-05-15

10.  Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33.

Authors:  Y Goshima; F Nakamura; P Strittmatter; S M Strittmatter
Journal:  Nature       Date:  1995-08-10       Impact factor: 49.962
View more
  7 in total

1.  Paraneoplastic cerebellar degeneration with anti-CV2/CRMP5 antibodies and prostate adenocarcinoma.

Authors:  A Aliprandi; A Terruzzi; A Rigamonti; E Bazzigaluppi; L Tremolizzo; C Ferrarese; A Salmaggi
Journal:  Neurol Sci       Date:  2015-02-17       Impact factor: 3.307

Review 2.  Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience.

Authors:  Maria Claudia Vigliani; Jerome Honnorat; Jean-Christophe Antoine; Roberta Vitaliani; Bruno Giometto; Dimitri Psimaras; Federica Franchino; Carlotta Rossi; Francesc Graus
Journal:  J Neurol       Date:  2011-05-11       Impact factor: 4.849

3.  Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes.

Authors:  D Ricard; V Rogemond; E Charrier; M Aguera; D Bagnard; M F Belin; N Thomasset; J Honnorat
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

4.  Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.

Authors:  J Honnorat; S Cartalat-Carel; D Ricard; J Ph Camdessanche; A F Carpentier; V Rogemond; F Chapuis; M Aguera; E Decullier; A M Duchemin; F Graus; J C Antoine
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-10-17       Impact factor: 10.154

Review 5.  Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders.

Authors:  Emmanuelle Charrier; Sophie Reibel; Véronique Rogemond; Michèle Aguera; Nicole Thomasset; Jérôme Honnorat
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.682

6.  Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature.

Authors:  Juan José Juárez-Vignon Whaley; Aurelio Carrera-Muiños; Karol Gema Hernandez-Gutierrez; Jerónimo Rafael Rodriguez-Cid; Maria Elisa Otero-Cerdeira; Vanessa Garcia-Montes
Journal:  Case Rep Oncol       Date:  2021-12-20

7.  Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer.

Authors:  Lan Wang; Haiyan Lou; Bo Li; Jun Li; Yun-Mei Yang
Journal:  Invest New Drugs       Date:  2021-07-21       Impact factor: 3.850
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.